Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-2290PMID 16510587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HGF/SF-Met signaling in tumor progression

  2005cited by this paper
• In Vivo Gene Transfer Using Direct Intramuscular Injection Approach

  2004cited by this paper
• Cyclooxygenase-2 Activation Mediates the Proangiogenic Effect of Nitric Oxide in Colorectal Cancer

  2004cited by this paper
• The biology of the P-glycoproteins

  2004cited by this paper
• RNA Interference Reveals that Ligand-Independent Met Activity Is Required for Tumor Cell Signaling and Survival

  2004cited by this paper
• Stimulation of in vitro angiogenesis by nitric oxide through the induction of transcription factor ETS-1.

  2004cited by this paper
• Met, metastasis, motility and more

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Angiogenesis: Tumorigenesis and the angiogenic switch

  2003cited by this paper
• Angiogenic Property of Hepatocyte Growth Factor Is Dependent on Upregulation of Essential Transcription Factor for Angiogenesis, ets-1

  2003influential reference
• A mechanism of cell survival: sequestration of Fas by the HGF receptor Met.

  2002cited by this paper
• Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti‐MDR1 ribozymes

  2002cited by this paper
• MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis.

  2002cited by this paper
• The MDR phenotype is associated with the expression of COX‐2 and iNOS in a human hepatocellular carcinoma cell line

  2002cited by this paper
• The prognostic molecular markers in hepatocellular carcinoma.

  2002cited by this paper
• Mutant p53 Cooperates with ETS and Selectively Up-regulates Human MDR1 Not MRP1*

  2001cited by this paper
• Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.

  2001cited by this paper
• Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.

  2001influential reference
• SF/HGF-c-Met autocrine and paracrine promote metastasis of hepatocellular carcinoma.

  2001cited by this paper
• Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1.

  2001cited by this paper
• Expression and possible role of ets-1 in hepatocellular carcinoma.

  2000cited by this paper
• Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma.

  2000cited by this paper
• Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis.

  2000cited by this paper
• ETS‐1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3

  1999influential reference
• Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).

  1998cited by this paper
• Cyclooxygenases 1 and 2.

  1998cited by this paper
• Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review).

  1998cited by this paper
• Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer.

  1998cited by this paper
• Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.

  1998cited by this paper
• p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells

  1998cited by this paper
• Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.

  1997cited by this paper
• Thrombopoietin-induced Expression of the Glycoprotein IIb Gene Involves the Transcription Factor PU.1/Spi-1 in UT7-Mpl Cells*

  1997cited by this paper
• Nitric oxide synthases: which, where, how, and why?

  1997cited by this paper
• 1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo*

  1997cited by this paper
• Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis

  1997cited by this paper
• Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

  1996cited by this paper
• Ets‐1 regulates angiogenesis by inducing the expression of urokinase‐type plasminogen activator and matrix metalloproteinase‐1 and the migration of vascular endothelial cells

  1996cited by this paper
• An Ets/Sp1 interaction in the 5'-flanking region of the megakaryocyte-specific alpha IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene.

  1996cited by this paper
• CANCER BIOLOGY: Expression of transforming growth factor alpha/epidermal growth factor receptor, hepatocyte growth factor/c- met and acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesis

  1996cited by this paper
• Mechanisms of Hepatocyte Growth Factor Stimulation of Keratinocyte Metalloproteinase Production*

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences (*)

  1996cited by this paper
• Roles of nitric oxide in tumor growth.

  1995cited by this paper
• Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction

  1995cited by this paper
• c‐met mRNA overexpression in human hepatocellular carcinoma

  1994cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis.

  1993cited by this paper
• Scatter factor induces blood vessel formation in vivo.

  1993cited by this paper
• Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

  1992cited by this paper
• Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth.

  1991cited by this paper
• The collagenase gene promoter contains a TPA and oncogene‐responsive unit encompassing the PEA3 and AP‐1 binding sites.

  1990cited by this paper
• Hepatitis B surface antigen produced by a human hepatoma cell line

  1979cited by this paper

• Scaffold-hopping strategy for pyrazolo[3,4-d]pyrimidines: In vitro and in silico studies of dual c-Met/STAT3 inhibition for enhanced antitumor activity.

  2025cites this paper
• MET-Targeting Anticancer Drugs—De Novo Design and Identification by Drug Repurposing

  2023cites this paper
• Acquisition of paclitaxel resistance modulates the biological traits of gastric cancer AGS cells and facilitates epithelial to mesenchymal transition and angiogenesis

  2022influential citation
• Dramatic Response to Cabozantinib in a Patient with Refractory Hepatocellular Carcinoma with c-MET Amplification

  2022cites this paper
• Mesenchymal Epithelial Transition Factor (MET): A Key Player in Chemotherapy Resistance and an Emerging Target for Potentiating Cancer Immunotherapy.

  2022cites this paper
• The role of MET in chemotherapy resistance

  2021cites this paper
• Studying Angiogenesis in the Rabbit Corneal Pocket Assay.

  2021cites this paper
• The role of extracellular matrix in tumour angiogenesis: the throne has NOx servants

  2020cites this paper
• Epigallocatechin‐3‐gallate sensitises multidrug‐resistant oral carcinoma xenografts to vincristine sulfate

  2020cites this paper
• High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma

  2020cites this paper
• NO and hepatocellular cancer

  2019cites this paper
• A meta-analysis of MDR1 polymorphisms rs1128503 and rs1045642 and susceptibility to hepatocellular carcinoma

  2019influential citation
• Clinical significance of expression of histone deacetylase 3 in hepatocellular carcinoma

  2017cites this paper
• Targeting MRP4 expression by anti-androgen treatment reverses MRP4-mediated docetaxel resistance in castration-resistant prostate cancer.

  2017cites this paper
• NF-κB and Its Implication in Liver Health and Cancer Development

  2017cites this paper
• The Rabbit Corneal Pocket Assay.

  2016cites this paper
• Hepatocellular carcinoma: Where are we?

  2016cites this paper
• Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines

  2015cites this paper
• Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane

  2015cites this paper
• The corneal pocket assay.

  2015cites this paper
• Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel.

  2015cites this paper
• Co-culture of hepatocytes with mesenchymal stem cells for cellular therapy in liver disease

  2014cites this paper
• Delivery of doxorubicin across the blood-brain barrier by ondansetron pretreatment: a study in vitro and in vivo.

  2014cites this paper
• HDAC3 acts as a negative regulator of angiogenesis

  2014cites this paper
• PTRF/cavin-1 is essential for multidrug resistance in cancer cells.

  2013cites this paper
• Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment.

  2012cites this paper
• Future directions in the evaluation of c-MET-driven malignancies

  2011cites this paper
• NK 4 Gene Expression Enhances 5-Fluorouracil-induced Apoptosis of Murine Colon Cancer Cells

  2011cites this paper
• NK4 gene expression enhances 5-fluorouracil-induced apoptosis of murine colon cancer cells.

  2011cites this paper
• A hepatoprotective Lindera obtusiloba extract suppresses growth and attenuates insulin like growth factor-1 receptor signaling and NF-kappaB activity in human liver cancer cell lines

  2011cites this paper
• Clinical value of serum interleukin-18 and nitric oxide activities in patients with prostate cancer

  2011cites this paper
• c-Met: A potential therapeutic target for hepatocellular carcinoma.

  2011cites this paper
• Application of biological study for met expression to cancer therapy.

  2010cites this paper
• EVALUATION OF CLINICAL AND LABORATORY PARAMETERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA Dissertation submitted in partial fulfillment of the requirements for the degree of D.M. (MEDICAL GASTROENTEROLOGY) Branch – IV THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY CHENNAI

  2010cites this paper
• Establishment of a human hepatoma multidrug resistant cell line in vitro.

  2010cites this paper
• Cytotoxic Effects of 2-Methoxyestradiol in the Hepatocellular Carcinoma Cell Line HepG2

  2009cites this paper
• The corneal pocket assay.

  2009cites this paper
• Molecular regulation of tumour angiogenesis by nitric oxide.

  2009cites this paper
• Potential cell signalling mechanisms involved in differential placental angiogenesis in mild and severe pre-eclampsia.

  2009cites this paper
• Alterations of cellular organelles in human liver-derived hepatoma G2 cells induced by adriamycin

  2009cites this paper
• P-170 peptides with low similarity to the human proteome: tracing an effective and safe biological way towards effective and safe cancer chemotherapy.

  2009cites this paper
• Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.

  2009cites this paper
• Chemotherapy and Novel Systemic Therapies

  2009cites this paper
• Expression of Hepatocyte Growth Factor and Basic Fibroblast Growth Factor as Prognostic Indicators in Gastric Cancer

  2009cites this paper
• A new Met inhibitory-scaffold identified by a focused forward chemical biological screen.

  2008cites this paper
• Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.

  2008cites this paper
• Single-Agent and CombinationTherapeutic Strategies to Inhibit Hepatocyte Growth Factor / MET Signaling in Cancer

  2008cites this paper
• Nitric Oxide in Tumor Angiogenesis

  2008cites this paper
• Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis.

  2008cites this paper
• Cell death signal by glycine- and proline-rich plant glycoprotein is transferred from cytochrome c and nuclear factor kappa B to caspase 3 in Hep3B cells.

  2008cites this paper
• Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy

  2008cites this paper
• Systemic Therapy for Hepatocellular Carcinoma

  2008cites this paper
• Hepatocellular carcinoma: epidemiology and clinical aspects.

  2008cites this paper
• Molecular targeted therapy for hepatocellular carcinoma

  2008cites this paper
• Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer

  2008cites this paper
• MDR1 gene polymorphisms and risk of recurrence in patients With hepatocellular carcinoma after liver transplantation

  2007cites this paper
• Chemotherapeutic stress selectively activates NF-kappa B-dependent AKT and VEGF expression in liver cancer-derived endothelial cells.

  2007cites this paper
• P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.

  2007cites this paper
• Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.

  2007cites this paper
• Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells

  2007cites this paper
• Corticotropin-releasing factor family and its receptors: tumor therapeutic targets?

  2007cites this paper
• The vascular compartments of neovascularization: spotlight on the microcirculation.

  2007cites this paper
• Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful?

  2007cites this paper
• P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines.

  2006cites this paper